Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A3 | P48764 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29392659 | 1.00 | SLC9A3 (0.30) | SLC9A3HTR2AHTR2CHTR2B | |
| SCHEMBL20634836 | 1.00 | SLC9A3 (0.30) | SLC9A3HTR2AHTR2CHTR2B | |
| SCHEMBL15821768 | 1.00 | SLC9A3 (0.30) | SLC9A3HTR2AHTR2CHTR2B | |
| SCHEMBL15827480 | 0.80 | KDM4E (0.31) | — | |
| SCHEMBL15808807 | 0.80 | KDM4E (0.31) | — | |
| SCHEMBL29390950 | 0.78 | — | — | |
| SCHEMBL20180232 | 0.78 | — | — | |
| SCHEMBL15822109 | 0.76 | UGT2B17 (0.35) | HTR2AHTR2CHTR2B | |
| SCHEMBL20018379 | 0.71 | — | — | |
| SCHEMBL15822592 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352376-B2 | Catalysts | BOREALIS AG (AT) | 2022-06-07 | — | — | US | disclosed |
| US-20190308995-A1 | CATALYSTS | BOREALIS AG (AT) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352376-B2 | Catalysts | SIGMAR1, H1-2, SFN | SLC9A3 1910/4885HTR2A 1980/4885HTR2C 723/4885 |
| US-20190308995-A1 | CATALYSTS | SIGMAR1, H1-2, CBR1 | SLC9A3 1942/4885HTR2A 1861/4885HTR2C 665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.